Opening book details…
About this book
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial by Bertrand Routy & John G. Lenehan & Wilson H. Miller & Rahima Jamal & Meriem Messaoudene & Brendan A. Daisley & Cecilia Hes & Kait F. Al & Laura Martinez-Gili & Michal Punamp#x0010D;ochamp#x000E1;amp#x00159; & Scott Ernst & Diane Logan & Karl Belanger &... is a book available to read on EtoBox.
- Author
- Bertrand Routy & John G. Lenehan & Wilson H. Miller & Rahima Jamal & Meriem Messaoudene & Brendan A. Daisley & Cecilia Hes & Kait F. Al & Laura Martinez-Gili & Michal Punamp#x0010D;ochamp#x000E1;amp#x00159; & Scott Ernst & Diane Logan & Karl Belanger &...
- Publisher
- Springer US
- Published
- 2023
- Language
- EN
More by Bertrand Routy & John G. Lenehan & Wilson H. Miller & Rahima Jamal & Meriem Messaoudene & Brendan A. Daisley & Cecilia Hes & Kait F. Al & Laura Martinez-Gili & Michal Punamp#x0010D;ochamp#x000E1;amp#x00159; & Scott Ernst & Diane Logan & Karl Belanger &...
Similar books
- Nivolumab Plus Ipilimumab in Advanced Salivary Gland Cancer: a Phase 2 Trial — Joris L. Vos & Bharat Burman & Swati Jain & Conall W. R. Fitzgerald & Eric J. Sherman & Lara A. Dunn & James V. Fetten & Loren S. Michel & Anuja Kriplani & Kenneth K. Ng & Juliana Eng & Vatche Tchekmedyian & Sofia Haque & Nora Katabi & Fengshen Kuo &... (2023)
- Ipilimumab with or Without Nivolumab in PD-1 or PD-L1 Blockade Refractory Metastatic Melanoma: a Randomized Phase 2 Trial — Ari VanderWalde & Shay L. Bellasea & Kari L. Kendra & Nikhil I. Khushalani & Katie M. Campbell & Philip O. Scumpia & Lawrence F. Kuklinski & Frances Collichio & Jeffrey A. Sosman & Alexandra Ikeguchi & Adrienne I. Victor & Thach-Giao Truong & Bartosz... (2023)
- Metronomic Chemotherapy Plus anti-PD-1 in Metastatic Breast Cancer: a Bayesian Adaptive Randomized Phase 2 Trial — Hongnan Mo & Yongpei Yu & Xiaoying Sun & Hewei Ge & Lanlan Yu & Xiuwen Guan & Jingtong Zhai & Aihua Zhu & Yuhan Wei & Jinjing Wang & Xiaoyan Yan & Haili Qian & Binghe Xu & Fei Ma (2024)
- Neoadjuvant anti-PD-1 Alone or in Combination with anti-TIGIT or an Oncolytic Virus in Resectable Stage IIIB–D Melanoma: a Phase 1/2 Trial — Reinhard Dummer & Caroline Robert & Richard A. Scolyer & Janis M. Taube & Michael T. Tetzlaff & Alexander M. Menzies & Andrew Hill & Jean-Jacques Grob & David C. Portnoy & Celeste Lebbe & Muhammad A. Khattak & Jonathan Cohen & Gil Bar-Sela & Inderjit... (2025)
- Tislelizumab Plus Zanubrutinib for Richter Transformation: the Phase 2 RT1 Trial — Othman Al-Sawaf & Rudy Ligtvoet & Sandra Robrecht & Janina Stumpf & Anna-Maria Fink & Eugen Tausch & Christof Schneider & Sebastian Boettcher & Martin Mikusko & Matthias Ritgen & Johannes Schetelig & Julia Tresckow & Ursula Vehling-Kaiser & Tobias... (2024)
- Amivantamab Plus Lazertinib in Osimertinib-relapsed EGFR-mutant Advanced Non-small Cell Lung Cancer: a Phase 1 Trial — Byoung Chul Cho & Dong-Wan Kim & Alexander I. Spira & Jorge E. Gomez & Eric B. Haura & Sang-We Kim & Rachel E. Sanborn & Eun Kyung Cho & Ki Hyeong Lee & Anna Minchom & Jong-Seok Lee & Ji-Youn Han & Misako Nagasaka & Joshua K. Sabari & Sai-Hong Ignatius... (2023)